Abstract:OBJECTIVE:To investigate the possibility of using generation 5 polyamidoamine dendrimers (G5-PAMAM-D) as gene vector for eukaryotic expression plasmid of siRNA in prostate carcinoma in vitro and vivo.METHODS:Firstly, eukaryotic expression vector of siRNA pSilencing 4.1-EGFP-shRNA, specific for enhanced green fluorescent protein (EGFP), pSilencing 4.1-STAT3-shRNA for signal transducers and activators of transcription 3 (STAT3) was constructed. pEGFP-C1 and pSilencing 4.1-EGFP-shRNA were cotransfected into prostate cancer cells PC-3 and 22Rv1 with G5-PAPAM-D as vector, and to observe silencing of EGFP. Next, pSilencing 4.1-STAT3-shRNA was transfected into PC-3 and 22Rv1 cells by G5-PAPAM-D, Western blotting and apoptosis staining was used to detect silencing of STAT3 and growth inhibition. Thirdly, BALB/C mice subcutaneous tumor model was made with PC-3 cells. Polyplex of G5-PAMAM-D and pSilencing 4.1-STAT3-shRNA was injected intratumorally. The tumor volume was measured and recorded.RESULTS:Fluorescence detection and Western blotting analysis demonstrated that G5-PAMAM-D was able to deliver Silencing 4.1-EGFP-shRNA and pSilencing 4.1-STAT3-shRNA into the two prostate cancer cell lines, and shRNA was expressed to induce silence of EGFP and STAT3. MTT results showed that proliferation of prostate cancer cells was suppressed by G5-PAMAM-D/pSilencing 4.1-STAT3-shRNA and induced apoptosis of PC-3 cells in vitro. Human prostate cancer in mice was successfully formed by inoculation of PC-3 cells into male BABL/C mice. In G5-PAMAM-D/pSilencing 4.1-STAT3-shRNA treated group, the tumor volume was shrank remarkably at 9 days after treatment and tumor growth was retarded compared with control groups.CONCLUSION:GS-PAMAM-D nanoparticles can be used to deliver plasmid vector expressing shRNA into prostate cancer cells effectively in vitro and vivo. It appears to be a promising gene vector for RNA interference therapy in prostate cancer.

Knockdown of STAT3 Expression in SKOV3 Cells by Biodegradable Sirna–plga/cso Conjugate Micelles

Efficient Delivery of Notch1 Sirna to Skov3 Cells by Cationic Cholesterol Derivative-Based Liposome

Knockdown of Stat3 Expression by RNAi Inhibits in Vitro Growth of Human Ovarian Cancer.

Effects on the STAT3-shRNA in Non-Small-Cell Lung Cancer Therapy: Design, Induction of Apoptosis, and Conjugation with Chitosan-Based Gene Vectors

Efficient Inhibition of Intraperitoneal Ovarian Cancer Growth in Nude Mice by Liposomal Delivery of Short Hairpin RNA Against STAT3

Study on the Inhibition of Non-Small Cell Lung Cancer Mediated by Chitosan-Based Gene Carrier Delivering STAT3-shRNA

Biocompatible Hydrogel Nanoparticles with Lysosomal Escape Properties for the Delivery of siRNA for the Gene Therapy of Colorectal Carcinoma

Inhibitory Effect of STAT3 Silenced with RNAi on Growth of Human Ovarian Cancer SKOV3 Cell Transplanted Tumor in Nude Mice

STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy

Preparation and characterization of lipid nanoparticle/pDNA complexes for STAT3 downregulation and overcoming chemotherapy resistance in lung cancer cells

Plasmid-Based Stat3 Sirna Delivered by Functional Graphene Oxide Suppresses Mouse Malignant Melanoma Cell Growth

Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells.

Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.

The Inhibition Study of STAT3 Sirna on Glioblastoma Stem Cells

[Inhibitory Effect of Silencing STAT3 Gene with Short Hairpin RNA Mediated by Polyamidoamine Dendrimers on Growth of Prostate Cancer].

Tumor targeted delivery of siRNA by a nano-scale quaternary polyplex for cancer treatment

Plasmid-based STAT3-siRNA Efficiently Inhibits Breast Tumor Growth and Metastasis in Mice.

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

Bioreducible, Arginine-Rich Polydisulfide-Based Sirna Nanocomplexes with Excellent Tumor Penetration for Efficient Gene Silencing.

Reduction Sensitive Nanocarriers Mpeg-G-γ-pga/ssbpei@sirna for Effective Targeted Delivery of Survivin Sirna Against NSCLC.

Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment